A multicentre, single-blind, randomized comparison of a fixed clindamycin phosphate/tretinoin gel formulation (Velac (R)) applied once daily and a clindamycin lotion formulation (Dalacin T (R)) applied twice daily in the topical treatment of acne vulgaris
Cc. Zouboulis et al., A multicentre, single-blind, randomized comparison of a fixed clindamycin phosphate/tretinoin gel formulation (Velac (R)) applied once daily and a clindamycin lotion formulation (Dalacin T (R)) applied twice daily in the topical treatment of acne vulgaris, BR J DERM, 143(3), 2000, pp. 498-505
Background A successful phase III pilot study compared the efficacy and saf
ety of a fixed clindamycin 1%/tretinoin 0 . 025% gel formulation (CTG; Vela
c (R) gel) applied once daily and a clindamycin 1% lotion formulation (CLN,
Dalacin T (R) lotion) applied twice daily in the treatment of moderate to
severe acne vulgaris.
Objectives We aimed to follow up this study.
Methods The two treatment regimens were compared in a multicentre, single-b
lind, randomized 12-week investigation of patients with moderate to severe
acne vulgaris.
Results At week 12, the mean percentage reduction in non-inflamed lesions (
open and closed comedones) was greater in the CTG group compared with the C
LN group (P = 0 . 05). Absolute reductions in open and closed comedones wer
e also greater in the CTG group, consistent with the comedolytic activity o
f tretinoin. There was a significantly greater absolute reduction in inflam
ed lesions (pustules, papules and nodules) from baseline to bath end-point
(last observed efficacy outcome: P = 0 . 043) and week 12 (P = 0 . 018) in
the CTG group compared with the CLN group. Evaluation of the calculated ove
rall acne severity score, considering all five lesion subtypes, demonstrate
d a significantly greater mean percentage reduction in the CTG group compar
ed with the CLN group, both at end-point (P = 0 . 01) and at week 12 (P < 0
. 01). The more subjective assessment of overall acne severity according t
o the Cook scale also demonstrated a significantly greater mean reduction i
n the CTG group than the CLN group after 12 weeks of therapy (P = 0 . 007).
CTG had a more rapid effect on the onset of improvement compared with CLN;
a 50% reduction in total lesion counts by day 60 was found in 77% of patie
nts on CTG compared with 56% receiving CLN (P = 0 . 003). This was largely
due to the reduction in open comedone counts (P = 0 . 0006). For all other
variables, CTG was at least as effective as CLN. Both treatments were well
tolerated.
Conclusions A single daily topical application of Velac (R) gel was superio
r to Dalacin T (R) lotion applied twice daily in reducing overall acne scor
es, and was faster acting, The simpler dosing regimen of Velac (R) gel and
its rapid effect are likely to have a positive effect on both patient compl
iance and cost.